Literature DB >> 344216

Comparative efficacy and toxicity of a ribosomal vaccine, acetone-killed cells, lipopolysaccharide, and a live cell vaccine prepared from Salmonella typhhimurium.

C R Angerman, T K Eisenstein.   

Abstract

The protective and toxic properties of a ribosomal vaccine prepared from Salmonella typhimurium W118-2 were systematicaly compared with those of an acetone-killed whole cell vaccine, purified lipopolysaccharide, and living cells in CD-1 mice. Tests of graded immunizing doses of each vaccine against several challenge doses of live strain W118-2 showed that, although the protection given by ribosomes approached the levels of protection conferred by living organisms, acetone-killed cells administered in appropriate dosages provided levels of protection comparable to that of ribosomes. Lipopolysaccharide was found to be significantly less protective than the other vaccines. On a dry-weight basis, ribosomes were the least toxic with a 50% toxic dose (TD50) of 5,000 microgram; acetone-killed cells had an intermediate TD50 of 1,400 microgram; and lipolysaccharide was the most toxic, with a TD50 of 320 microgram. The dose of each vaccine that protected 50% of the mice against a challenge of 1,00 times the 50% lethal dose was determined and divided by the TD50 to give the therapeutic index. This ratio also indicated that the ribosomes and acetone-killed cells were equally effective, whereas lipopolysaccharide was markedly inferior.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 344216      PMCID: PMC414122          DOI: 10.1128/iai.19.2.575-582.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  CONTROLLED FIELD TRIAL IN BRITISH GUIANA SCHOOL CHILDREN OF HEAT-KILLED-PHENOLIZED AND ACETONE-KILLED LYOPHILIZED TYPHOID VACCINES.

Authors:  M T ASHCROFT; J M RITCHIE; C C NICHOLSON
Journal:  Am J Hyg       Date:  1964-03

2.  Studies on the experimental typhoid. 1. A comparative study of living and killed vaccines against the infection of mice with S. enteritidis.

Authors:  S MITSUHASHI; M KAWAKAMI; Y YAMAGUCHI; M NAGAI
Journal:  Jpn J Exp Med       Date:  1958-08

3.  Enhancement of the immunogenicity of typhoid vaccine by retention of the V1 antigen.

Authors:  M LANDY
Journal:  Am J Hyg       Date:  1953-09

4.  Experimental salmonellosis: differential passive transfer of immunity with serum and cells obtained from ribosomal and ribonucleic acid-immunized mice.

Authors:  M R Venneman; L J Berry
Journal:  J Reticuloendothel Soc       Date:  1971-05

5.  The specificity and importance of humoral antibody in the protection of mice against intraperitoneal challenge with complement-sensitive and complement-resistant Salmonella.

Authors:  E P Ornellas; R J Roantree; J P Steward
Journal:  J Infect Dis       Date:  1970-02       Impact factor: 5.226

6.  Early antibody response in mice to either infection or immunization with Salmonella typhimurium.

Authors:  K Kenny; M Herzberg
Journal:  J Bacteriol       Date:  1967-03       Impact factor: 3.490

7.  Two types of immunity in experimental typhoid; "cellular immunity" and "humoral immunity".

Authors:  D Ushiba
Journal:  Keio J Med       Date:  1965-06

8.  Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.

Authors:  M R Venneman; N J Bigley
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

9.  Infection-immunity in experimental salmonellosis.

Authors:  F M Collins; G B Mackaness; R V Blanden
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

10.  Host-parasite relations in mouse typhoid.

Authors:  G B Mackaness; R V Blanden; F M Collins
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  23 in total

Review 1.  Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge.

Authors:  Raphael Simon; Sharon M Tennant; James E Galen; Myron M Levine
Journal:  Vaccine       Date:  2011-05-25       Impact factor: 3.641

2.  Analysis of immunity to infection with Salmonella typhimurium in outbred mice. II. Isolation and immunogenicity of the protective non-O antigenic component from ribosomal vaccine.

Authors:  E Kita; M Emoto; N Katsui; K Nishi; K Yasui; K Yasui; S Kashiba
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

3.  Protective immunity induced by outer membrane proteins of Salmonella typhimurium in mice.

Authors:  V Udhayakumar; V R Muthukkaruppan
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

4.  Immunomodulation of the antibody response to lipopolysaccharide in C3H/HeJ mice by complexing with heterologous ribosomes.

Authors:  M Phillips; T K Eisenstein; J Meissler
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

5.  Correlation of the duration and magnitude of protection against Salmonella infection afforded by various vaccines with antibody titers.

Authors:  C R Angerman; T K Eisenstein
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

6.  Phagocytosis and killing of salmonella typhimurium by peritoneal exudate cells.

Authors:  D E Briles; J Lehmeyer; C Forman
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

7.  Dissociation of innate susceptibility to Salmonella infection and endotoxin responsiveness in C3HeB/FeJ mice and other strains in the C3H lineage.

Authors:  T K Eisenstein; L W Deakins; L Killar; P H Saluk; B M Sultzer
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

8.  Induction of immunoenhancing factors for murine splenocyte cultures by Salmonella typhimurium ribosome and ribonucleic acid extracts.

Authors:  R C Butler; H Friedman; S C Specter; T K Eisenstein
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

9.  Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice.

Authors:  S B Svenson; A A Lindberg
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

10.  Immunization of mice with Trypanosoma cruzi polyribosomes.

Authors:  L L Leon; W Leon; L Chaves; S C Costa; M Q Cruz; H M Brascher; A O Lima
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.